Welcome to our new website
Increased Overall Survival (OS) of patients with pancreatic cancer: results of a Phase III study of adjuvant mFOLFIRINOX presented at…
Information letter – Yakult, our partner in Japan, announced the approval of Elplat in Gastric Cancer
Biocartis Successful IPO – The Start of a New Era
